Javascript must be enabled to continue!
Abstract 1844: xCT promotes tumor formation in airway epithelial cells by activation MYC and WNT pathways
View through CrossRef
Abstract
INTRODUCTION: Many tumors increase uptake and dependence on nutrients such as glucose, cysteine or glutamine. These basic observations on cancer cell metabolism have opened multiple new diagnostic and therapeutic avenues in cancer. Recent studies demonstrated that smoking can induce the expression of xCT (SLC7A11) in normal epithelial cells and cancer cells, suggesting that overexpression of xCT may support lung tumor progression. These basic observations on cancer cell metabolism have opened multiple new diagnostic and therapeutic avenues in cancer. Here, we investigated the function of SLC7A11 (xCT), a cystine/glutamate anti-porter, in the pathogenesis of lung cancer. Recently, we found xCT to be strongly overexpressed at the cell surface of lung cancers and began to investigate the mechanisms by which xCT may contribute to lung cancer progression.
METHODS: We overexpressed the xCT in mutiple non-tumorgenic cell lines. These cell lines included 16HBE, BEAS2B, HBEC_KTR_P53_C7, and HEK293. We further investigated the role of xCT in cell proliferation, conly formation, and tumor formation in nude mice. Finally, we used RNAseq analysis to indentify the molecular mechanims associated with xCT expression in HEK293 cells.
RESULTS: Our results shows that xCT overexpression transformed the normal airway epithelium cell lines (HBEC3_KTR_P53_C7). The overexpression of xCT in HBEC_KTR_P53C7 induced colony formation in soft agar and promoted cell proliferation. In addition, we found overexpression of xCT reprogrammed multiple metabolic pathways such as glycolysis, glutaminolysis, and pentose phosphate pathway. In addition, we found overexpression of xCT could transform non-tumorigenic cell line HBEC_KTR_P53_C7 to tumor-formation cell line. Our RNAseq data indicated that this transformation is enriched in MYC and WNT pathway.
CONCLUSION: Our results demonstrate that xCT is highly expressed in a subset of NSCLCs. The induction of xCT in transformed aiway epithelial cells causes tumor formation in nude mice. The mechanism of malignant transformation involves the Warburg effect. Further investigation into the mechanisms of transformation may help in answering fundamental questions pertaining to how glutamate/cystine exchange contributes to lung cancer development and progression and also in establishing xCT as a potential novel therapeutic target in lung cancer.
Key words: Non-small cell lung cancer, amino acid transporters, metabolic reprogramming
Note: This abstract was not presented at the meeting.
Citation Format: Xiangming Ji. xCT promotes tumor formation in airway epithelial cells by activation MYC and WNT pathways [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 1844.
Title: Abstract 1844: xCT promotes tumor formation in airway epithelial cells by activation MYC and WNT pathways
Description:
Abstract
INTRODUCTION: Many tumors increase uptake and dependence on nutrients such as glucose, cysteine or glutamine.
These basic observations on cancer cell metabolism have opened multiple new diagnostic and therapeutic avenues in cancer.
Recent studies demonstrated that smoking can induce the expression of xCT (SLC7A11) in normal epithelial cells and cancer cells, suggesting that overexpression of xCT may support lung tumor progression.
These basic observations on cancer cell metabolism have opened multiple new diagnostic and therapeutic avenues in cancer.
Here, we investigated the function of SLC7A11 (xCT), a cystine/glutamate anti-porter, in the pathogenesis of lung cancer.
Recently, we found xCT to be strongly overexpressed at the cell surface of lung cancers and began to investigate the mechanisms by which xCT may contribute to lung cancer progression.
METHODS: We overexpressed the xCT in mutiple non-tumorgenic cell lines.
These cell lines included 16HBE, BEAS2B, HBEC_KTR_P53_C7, and HEK293.
We further investigated the role of xCT in cell proliferation, conly formation, and tumor formation in nude mice.
Finally, we used RNAseq analysis to indentify the molecular mechanims associated with xCT expression in HEK293 cells.
RESULTS: Our results shows that xCT overexpression transformed the normal airway epithelium cell lines (HBEC3_KTR_P53_C7).
The overexpression of xCT in HBEC_KTR_P53C7 induced colony formation in soft agar and promoted cell proliferation.
In addition, we found overexpression of xCT reprogrammed multiple metabolic pathways such as glycolysis, glutaminolysis, and pentose phosphate pathway.
In addition, we found overexpression of xCT could transform non-tumorigenic cell line HBEC_KTR_P53_C7 to tumor-formation cell line.
Our RNAseq data indicated that this transformation is enriched in MYC and WNT pathway.
CONCLUSION: Our results demonstrate that xCT is highly expressed in a subset of NSCLCs.
The induction of xCT in transformed aiway epithelial cells causes tumor formation in nude mice.
The mechanism of malignant transformation involves the Warburg effect.
Further investigation into the mechanisms of transformation may help in answering fundamental questions pertaining to how glutamate/cystine exchange contributes to lung cancer development and progression and also in establishing xCT as a potential novel therapeutic target in lung cancer.
Key words: Non-small cell lung cancer, amino acid transporters, metabolic reprogramming
Note: This abstract was not presented at the meeting.
Citation Format: Xiangming Ji.
xCT promotes tumor formation in airway epithelial cells by activation MYC and WNT pathways [abstract].
In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA.
Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 1844.
Related Results
Improving immunotherapy in high-grade B-cell lymphoma
Improving immunotherapy in high-grade B-cell lymphoma
MYC is a transcription factor that upon deregulation acts as an oncogene. Cancer patients with MYC overexpression face significant worse outcomes to treatment with (immuno)chemothe...
<i>MYC</i> rearrangement but not extra <i>MYC</i> copies is an independent prognostic factor in patients with mantle cell lymphoma
<i>MYC</i> rearrangement but not extra <i>MYC</i> copies is an independent prognostic factor in patients with mantle cell lymphoma
Mantle cell lymphoma (MCL) with MYC rearrangement (MYC-R) is rare and little is known about the importance of MYC extra copies (EC) in the absence of MYC-R in MCL patients. This st...
Abstract 5833: Targeting the transcription co-activator TAZ inhibits MYC-driven medulloblastoma
Abstract 5833: Targeting the transcription co-activator TAZ inhibits MYC-driven medulloblastoma
Abstract
Medulloblastoma (MB), the most common malignant pediatric brain tumor, results in significant neurological, intellectual and physical disability or death. F...
Abstract 1872: Targeting MYC-driven medulloblastoma using inhibitors of glutamine metabolism.
Abstract 1872: Targeting MYC-driven medulloblastoma using inhibitors of glutamine metabolism.
Abstract
Medulloblastoma is the most common malignant brain tumor in children. Currently, treatment consists of surgical resection, chemotherapy, and whole brain and...
Abstract 3333: Cancer stem cell-mediated regulation of Myc overexpressing medulloblastoma cells on proliferation, migration and invasion
Abstract 3333: Cancer stem cell-mediated regulation of Myc overexpressing medulloblastoma cells on proliferation, migration and invasion
Abstract
Medulloblastoma (MB) is the most common and malignant pediatric brain tumor. Myc amplification was frequently shown in the tumor. Hereby cancer stem cells a...
Abstract PO-037: Machine learning-enabled transomics identifies three therapeutic targets for MYC-driven diffuse large B cell lymphoma
Abstract PO-037: Machine learning-enabled transomics identifies three therapeutic targets for MYC-driven diffuse large B cell lymphoma
Abstract
MYC activation and dysregulation is a powerful oncogenic driver in multiple cancers, including diffuse large B cell lymphoma (DLBCL). There is a known corre...
Abstract 5051: MYC-driven models of primitive neuroectodermal tumor are sensitive to inhibitors of glutamine metabolism.
Abstract 5051: MYC-driven models of primitive neuroectodermal tumor are sensitive to inhibitors of glutamine metabolism.
Abstract
Brain tumors are a diverse group of cancers in which alterations in growth regulation pathways drive tumorigenicity. Histologically similar tumors may have ...
Abstract 1689: The cytoprotective role of the UPR during c-Myc dependent transformation and tumor progression.
Abstract 1689: The cytoprotective role of the UPR during c-Myc dependent transformation and tumor progression.
Abstract
The Unfolded Protein Response (UPR) is a conserved cellular adaptation program that is elicited due to the accumulation of unfolded proteins in the endoplas...


